Jose Manuel Ruiz-Morales

Dr. Jose Manuel Ruiz-Morales


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
JRJose Manuel Ruiz-Morales
Jose Manuel Ruiz-Morales
RDRita Dorantes-Heredia
Rita Dorantes-Heredia
OAOscar Arrieta
Oscar Arrieta
NCNorberto Chavez-Tapia
Norberto Chavez-Tapia
DMDaniel Motola-Kuba
Daniel Motola-Kuba

1 January 2019 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
RDRita Dorantes-Heredia
Rita Dorantes-Heredia
DMDaniel Motola-Kuba
Daniel Motola-Kuba
CMCarlos Murphy-Sanchez
Carlos Murphy-Sanchez
CICarlos D Izquierdo-Tolosa
Carlos D Izquierdo-Tolosa
JRJose Manuel Ruiz-Morales
Jose Manuel Ruiz-Morales
Testicular germ cell tumors (TGCTs) are the most frequent type of cancer in young adults. An exceptional event is the spontaneous regression (SR) of the primary tumor. Herein, we describe a burned-out non-seminomatous TGCT case and relevant literature review. A 34-year-old male presenting with low back pain was found to have a retroperitoneal mass upon urotomography. During workup, a heterogeneous testicular mass was evident, and its biopsy showed findings that support the diagnosis of spontaneous tumoral regression. The patient underwent unilateral orchiectomy and a chemotherapy protocol was later initiated, with 85% regression of the retroperitoneal metastatic mass. No progression of the primary tumor has been found. The etiology of SR across different cancer types appears to be associated with the host’s immune response and an angiogenic disturbance of the tumor microenvironment. The burned-out phenomenon is a rare event that needs further research into its molecular sequencing.

20 December 2021 in Case Reports in Oncology
Verified
Journal Article
Open access
PDF file
RFRicardo Fernández-Ferreira
Ricardo Fernández-Ferreira
EMEmilio Medina-Ceballos
Emilio Medina-Ceballos
PSPamela Denisse Soberanis-Piña
Pamela Denisse Soberanis-Piña
ECEmilio Conde-Flores
Emilio Conde-Flores
AAAndrés Mauricio Arroyave-Ramírez
Andrés Mauricio Arroyave-Ramírez
RDRita Dorantes-Heredia
Rita Dorantes-Heredia
Carcinoma of the extrahepatic biliary tract accounts for <2% of all cancers. Neuroendocrine tumor of the extrahepatic bile duct is very rare, and there are <200 cases reported since 1959. The preoperative diagnosis is infrequent (5.12%). The definite diagnosis relies on postoperative pathology which utilized immunohistochemistry study on many biomarkers to diagnose the histological subtypes of neuroendocrine neoplasms, such as chromogranin A, synaptophysin, and neuron-specific enolase. When the primary tumor has no metastases, radical removal of the lesion appears as curative treatment. The treatment of the carcinoid syndrome or other functioning syndrome is the first priority. We report a case of a 12-year-old Mexican woman with neuroendocrine tumor of the extrahepatic bile duct (common bile duct neuroendocrine tumor) seen in our hospital. Resection of the common bile duct, cholecystectomy, end to side Roux-en-y hepaticojejunostomy, and portal lymphadenectomy was performed. A review of the pertinent literature was performed. Given the rarity of the disease, treatment principles are based mainly on retrospective series and case reports. We present the eighth case in adolescence in the literature.

18 June 2024 in Case Reports in Oncology
Verified
Journal Article
Open access
PDF file
RFRicardo Fernández-Ferreira
Ricardo Fernández-Ferreira
JTJose Manuel Torres-Zazueta
Jose Manuel Torres-Zazueta
CMCésar Martínez-Medrano
César Martínez-Medrano
AMAdrián Meléndez-Mendoza
Adrián Meléndez-Mendoza
STSonia Tavares-García
Sonia Tavares-García
JRJose Manuel Ruiz-Morales
Jose Manuel Ruiz-Morales
Introduction: Nephroblastoma, or Wilms’ tumor, is a malignant renal neoplasm commonly found in children, is extremely rare in adults representing only 0.5% of all renal neoplasms. Adult Wilms tumor is rare, to our knowledge fewer than 300 cases have been reported in the English literature to date. However, in older adults after 60 years of age, only less than 45 cases have been reported. For this reason, treatment guidelines in adults still are lacking. Prognosis in nephroblastoma for adult patients is found to be worse than in children. Case Presentation: We report the case of a 65-year-old female with lumbar fossa mass, flank pain and hematuria, and pathologic diagnosis of Wilms tumor. We performed nephrectomy. No adjuvant treatment was given. Our patient remains asymptomatic and without evidence of recurrence 12 months after the surgery. Conclusion: Nephroblastoma in the elderly presents different clinical behavior and prognosis compared to nephroblastoma in children.

1 December 2021 in JCO Clinical Cancer Informatics
Verified
Journal Article
Closed access
KSKevin Shee
Kevin Shee
SPSumanta K Pal
Sumanta K Pal
CWConnor Wells
Connor Wells
JRJose Manuel Ruiz-Morales
Jose Manuel Ruiz-Morales
KRKenton Russell
Kenton Russell
AOAnobel Y. Odisho
Anobel Y. Odisho
PURPOSE: Patients and providers often lack clinical decision tools to enable effective shared decision making. This is especially true in the rapidly changing therapeutic landscape of metastatic kidney cancer. Using the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) criteria, a validated risk prediction tool for patients with metastatic renal cell carcinoma, we created and user-tested a novel interactive visualization for clinical use. METHODS: An interactive visualization depicting IMDC criteria was created, with the final version including data for more than 4,500 patients. Usability testing was performed with nonmedical lay-users and medical oncology fellow physicians. Subjects used the tool to calculate median survival times based on IMDC criteria. User confidence was surveyed. An iterative user feedback implementation cycle was completed and informed revision of the tool. RESULTS: The tool is available at CloViz—IMDC. Initially, 400 lay-users and 15 physicians completed clinical scenarios and surveys. Cumulative accuracy across scenarios was higher for physicians than lay-users (84% v 74%; P = .03). Eighty-three percent of lay-users and 87% of physicians thought the tool became intuitive with use. Sixty-eight percent of lay-users wanted to use the tool clinically compared with 87% of physicians. After revisions, the updated tool was user-tested with 100 lay-users and 15 physicians. Physicians, but not lay-users, showed significant improvement in accuracy in the updated version of the tool (90% v 67%; P = .008). Seventy-two percent of lay-users and 93% of physicians wanted to use the updated tool in a clinical setting. CONCLUSION: A graphical method of interacting with a validated nomogram provides prognosis results that can be used by nonmedical lay-users and physicians, and has the potential for expanded use across many clinical conditions.

1 October 2021 in World Journal of Oncology
Verified
Journal Article
Open access
PDF file
DDDavid Davila Dupont
David Davila Dupont
DKDaniel Motola Kuba
Daniel Motola Kuba
TVThalia de Los Milagros Alcantara Velarde
Thalia de Los Milagros Alcantara Velarde
ECErika Adriana Martinez Castaneda
Erika Adriana Martinez Castaneda
RHRita Dorantes Heredia
Rita Dorantes Heredia
JRJose Manuel Ruiz-Morales
Jose Manuel Ruiz-Morales
Impact of Testicular Germ Cell Tumor Laterality on Recurrence-Free Survival in the Mexican Population